ADB-5'Br-BUTINACA-d9 (CRM) (Synonyms: ADB-5'Br-BINACA-d9,ADB-BUT-5Br-INACA-d9) |
| Catalog No.GC91772 |
ADB-5'Br-BUTINACA-d9 (CRM) is intended for use as an internal standard for the quantification of ADB-5'Br-BUTINACA by GC- or LC-MS.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: N/A
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
ADB-5'Br-BUTINACA-d9 (CRM) is intended for use as an internal standard for the quantification of ADB-5'Br-BUTINACA by GC- or LC-MS. ADB-5'Br-BUTINACA is categorized as a synthetic cannabinoid.1 This product is intended for research and forensic applications.
References:
[1].Deventer, M.H., Persson, M., Norman, C., et al.In vitro cannabinoid activity profiling of generic ban-evading brominated synthetic cannabinoid receptor agonists and their analogsDrug Test. Anal.(2023).
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *